Shares of Corcept Therapeutics Incorporated (NASDAQ: CORT), a company focused on developing drugs for the treatment of a variety of cortisol hormone related disorders, finished the week down about 14.2% after an 8.8% slide in Friday’s session. A solid fourth-quarter earnings report read more